tomeko

Autosomal recessive limb-girdle muscular dystrophy type 2O

Just diagnosed with Autosomal recessive limb-girdle muscular dystrophy type 2O?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Autosomal recessive limb-girdle muscular dystrophy type 2O, look for clinical trials, and connect with others living with it — all in one place.

Open the full Autosomal recessive limb-girdle muscular dystrophy type 2O hub →

Overview

Autosomal recessive limb-girdle muscular dystrophy type 2O is a rare condition. Also known as Autosomal recessive limb-girdle muscular dystrophy type 2O, LGMD type 2O, LGMD2O, Limb-girdle muscular dystrophy type 2O, POMGNT1-related LGMD R15. Tomeko brings together the specialists, research, clinical trials, treatments and community for Autosomal recessive limb-girdle muscular dystrophy type 2O so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:206564 · OMIM 613157 · ICD-10 G71.0 · GARD 0012540

Find care for Autosomal recessive limb-girdle muscular dystrophy type 2O

Authoritative references for Autosomal recessive limb-girdle muscular dystrophy type 2O

Common questions

I was just diagnosed with Autosomal recessive limb-girdle muscular dystrophy type 2O — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Autosomal recessive limb-girdle muscular dystrophy type 2O, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Autosomal recessive limb-girdle muscular dystrophy type 2O?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Autosomal recessive limb-girdle muscular dystrophy type 2O, filtered to your area.

Are there clinical trials for Autosomal recessive limb-girdle muscular dystrophy type 2O?

Tomeko shows live, recruiting studies for Autosomal recessive limb-girdle muscular dystrophy type 2O from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com